Collegium Pharmaceutical, Inc. (COLL)
24.64
-0.71
(-2.80%)
USD |
NASDAQ |
Aug 31, 16:00
24.64
0.00 (0.00%)
After-Hours: 16:06
Collegium Pharmaceutical Cash and Short Term Investments (Quarterly) : 149.32M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 149.32M |
| March 31, 2026 | 441.60M |
| December 31, 2025 | 406.53M |
| September 30, 2025 | 305.71M |
| June 30, 2025 | 242.00M |
| March 31, 2025 | 217.63M |
| December 31, 2024 | 187.76M |
| September 30, 2024 | 144.96M |
| June 30, 2024 | 271.63M |
| March 31, 2024 | 318.05M |
| December 31, 2023 | 310.55M |
| September 30, 2023 | 304.56M |
| June 30, 2023 | 325.47M |
| March 31, 2023 | 269.48M |
| December 31, 2022 | 173.69M |
| September 30, 2022 | 134.13M |
| June 30, 2022 | 122.72M |
| March 31, 2022 | 106.70M |
| December 31, 2021 | 186.43M |
| September 30, 2021 | 193.24M |
| June 30, 2021 | 202.77M |
| March 31, 2021 | 182.79M |
| December 31, 2020 | 174.12M |
| Date | Value |
|---|---|
| September 30, 2020 | 165.42M |
| June 30, 2020 | 145.68M |
| March 31, 2020 | 116.18M |
| December 31, 2019 | 170.02M |
| September 30, 2019 | 153.84M |
| June 30, 2019 | 148.71M |
| March 31, 2019 | 134.91M |
| December 31, 2018 | 146.63M |
| September 30, 2018 | 139.79M |
| June 30, 2018 | 133.75M |
| March 31, 2018 | 128.25M |
| December 31, 2017 | 118.70M |
| September 30, 2017 | 107.61M |
| June 30, 2017 | 111.21M |
| March 31, 2017 | 129.56M |
| December 31, 2016 | 153.22M |
| September 30, 2016 | 91.03M |
| June 30, 2016 | 110.75M |
| March 31, 2016 | 134.73M |
| December 31, 2015 | 95.70M |
| September 30, 2015 | 105.46M |
| June 30, 2015 | 112.41M |
| March 31, 2015 | 44.99M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Innoviva, Inc. | 579.06M |
| Zevra Therapeutics, Inc. | 221.57M |
| Supernus Pharmaceuticals, Inc. | 372.07M |
| Indivior Pharmaceuticals, Inc. | 222.00M |
| Crinetics Pharmaceuticals, Inc. | 1.206B |